OR

Orit Rozenblatt-Rosen

MIT: 6 patents #6 of 955Top 1%
TI The Broad Institute: 6 patents #3 of 203Top 2%
DI Dana-Farber Cancer Institute: 4 patents #5 of 212Top 3%
BH Brigham and Women's Hospital: 3 patents #8 of 221Top 4%
📍 Cambridge, MA: #58 of 1,960 inventorsTop 3%
🗺 Massachusetts: #443 of 14,432 inventorsTop 4%
Overall (2024): #22,862 of 561,600Top 5%
6
Patents 2024

Issued Patents 2024

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
12043870 Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer Aviv Regev, Benjamin Izar, Livnat Jerby, Asaf Rotem 2024-07-23
12036240 Compositions and methods targeting complement component 3 for inhibiting tumor growth Aviv Regev, Ana Carrizosa Anderson, Ayshwarya Subramanian 2024-07-16
11981922 Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment Meromit Singer, Aviv Regev, Davide Mangani, Ana Carrizosa Anderson, Vijay K. Kuchroo +1 more 2024-05-14
11963966 Compositions and methods for treating ovarian tumors Levi A. Garraway, Benjamin Izar, Aviv Regev, Asaf Rotem, Elizabeth Stover +1 more 2024-04-23
11913075 Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer Aviv Regev, Benjamin Izar, Livnat Jerby, Asaf Rotem 2024-02-27
11897953 Compositions and methods targeting complement component 3 for inhibiting tumor growth Aviv Regev, Ana Carrizosa Anderson, Ayshwarya Subramanian 2024-02-13